| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 03/21/2007 | EP1467711B1 Dna dosage forms |
| 03/21/2007 | EP1465607B1 Pharmaceutical formulations with modified release |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1339415B1 composition of multipurpose high functional alkaline solution composition, preparation thereof, and use as nonspecific immunostimulator |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP1126876B1 Adjuvant systems and vaccines |
| 03/21/2007 | EP1115425B1 Autoantibody inhibitors |
| 03/21/2007 | EP1102600B1 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 03/21/2007 | EP1049717B1 Antibodies against human il-12 |
| 03/21/2007 | EP1007088B1 Recombinant porcine adenovirus vector |
| 03/21/2007 | CN1934069A 氨基酸衍生物 Amino acid derivatives |
| 03/21/2007 | CN1931872A Casein hydrolysate and its prepn process |
| 03/21/2007 | CN1931859A New fused imidazole derivative |
| 03/21/2007 | CN1931851A Compound 2,3,4,6,8-pentamethoxyl-dibenzofuran and its use |
| 03/21/2007 | CN1931365A Hcv e1e2 vaccine compositions |
| 03/21/2007 | CN1931359A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931358A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931353A Curcuma extract and its prepn process, medicine composition and use |
| 03/21/2007 | CN1931352A Chinese medicine composition and its prepn process |
| 03/21/2007 | CN1931344A Medicine ointment for treating allergic rhinitis and its production process |
| 03/21/2007 | CN1931320A Medicinal wine composition and its prepn process |
| 03/21/2007 | CN1931303A Pilose antler-glossy ganoderma capsule |
| 03/21/2007 | CN1931299A Chinese herbal medicine enama for treating immunological eye diseases and its prepn process |
| 03/21/2007 | CN1931259A Process of extracting effective component from papaya |
| 03/21/2007 | CN1931219A Gynostemma pentaphylla micro emulsion medicine and its prepn |
| 03/21/2007 | CN1931186A Application of arsenous oxide in preparing medicine for treating embryo cell diseases sensitive to arsenide |
| 03/21/2007 | CN1305906C Use of antibodies against specific MHC-Peptide complexes |
| 03/21/2007 | CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305528C Immunoadjuvant |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/21/2007 | CN1305465C Cell growth regulating factor I and its preparation process |
| 03/20/2007 | US7193108 Phenylpropionic acid derivatives |
| 03/20/2007 | US7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 03/20/2007 | US7193064 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192928 T cell antigen receptor peptides |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192616 Slow down or even inhibit cellular differentiation and/or proliferation. |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192580 Purging of cells using viruses |
| 03/15/2007 | WO2007029760A1 Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 03/15/2007 | WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 03/15/2007 | WO2007028968A1 Method of treating myasthenia gravis |
| 03/15/2007 | WO2006123230A3 Compositions for antigen-specific induction of immuno-tolerance via oral immunization |
| 03/15/2007 | WO2006106437A8 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 03/15/2007 | WO2006103429A3 High affinity hiv t cell receptors |
| 03/15/2007 | WO2003068169A3 Stabilized synthetic immunogen delivery system |
| 03/15/2007 | US20070060754 Alkoxy substituted imidazoquinolines |
| 03/15/2007 | US20070060647 Gene expression regulating agent |
| 03/15/2007 | US20070060603 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 03/15/2007 | US20070060594 Pyridinyl acetonitriles |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto |
| 03/15/2007 | US20070060511 Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059756 Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies |
| 03/15/2007 | US20070059689 Hybrid glycosylated products and their production and use |
| 03/15/2007 | US20070059684 Method of identifying an antiviral agent |
| 03/15/2007 | US20070059317 Potent immunostimulants from microalgae |
| 03/15/2007 | US20070059314 Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/15/2007 | US20070059290 Transcriptional regulation of target genes |
| 03/15/2007 | CA2820510A1 Treatment of autoimmune diseases |
| 03/15/2007 | CA2808179A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 03/15/2007 | CA2621697A1 Method of treating myasthenia gravis comprising a ev576 or omcl protein |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | EP1762557A2 Aspirin-triggered lipid mediators |
| 03/14/2007 | EP1762248A1 Use of cobalt porphyrins in joint therapy with an immunosuppressant drug for treatment of transplant patients or autoimmune disorders |
| 03/14/2007 | EP1762236A2 Formulations of alpha adrenergic receptor antagonists and their uses |
| 03/14/2007 | EP1761540A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 03/14/2007 | EP1761496A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
| 03/14/2007 | EP1761494A1 Chemical compounds i |
| 03/14/2007 | EP1761485A1 Amidino compounds as cysteine protease inhibitors |
| 03/14/2007 | EP1761276A2 Compositions and methods for treating neurological disorders |
| 03/14/2007 | EP1761256A1 Cla-enriched milkfat and uses thereof |
| 03/14/2007 | EP1515949B1 Mitotic kinesin inhibitors |
| 03/14/2007 | EP1497417B1 Epha2 antigen t epitopes |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | EP1448235B1 Oral controlled release pharmaceutical compositions of 5,8,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 03/14/2007 | EP1385502B1 Medicament comprising an anhydrous formulation of xanthogenate |
| 03/14/2007 | EP1254180B1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 03/14/2007 | EP1227838B1 Melanoma vaccine and methods of making and using same |
| 03/14/2007 | EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 03/14/2007 | EP1071411B1 Topical immunostimulation to induce langerhans cell migration |
| 03/14/2007 | EP1067956B1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |
| 03/14/2007 | EP0975351B1 Treatment of multiple sclerosis through ingestion of copolymer-1 |
| 03/14/2007 | EP0966302B1 Methods of therapeutic administration of anti-cd40l compounds |